HomeMarketsSharesOrthoPediatrics Corp

Trade OrthoPediatrics Corp - KIDS CFD

Market is not available at the momentMarket information is presented
as of 2026-09-28T19:48:01+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.14
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022262 %
(-$4.45)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02226%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00004 %
($0.01)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


0.00004%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close22.48
Open22.2
1-Year Change21.78%
Day's Range22.2 - 22.52

Trade OrthoPediatrics Corp - KIDS

About Orthopediatrics Corp

OrthoPediatrics Corp. is a medical device company, which is designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company operates through the OrthoPediatrics Segment, which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. The Company offers a range of products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform Femur, Orthex, QuickPack and ApiFix Mid-C System, to various hospitals and medical facilities throughout the United States and various international markets.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Orthopediatrics Corp revenues increased 38% to $98M. Net loss decreased 51% to $16.3M. Revenues reflect Trauma and Deformity segment increase of 38% to $65.8M, Scoliosis segment increase of 35% to $28M, U.S. segment increase of 24% to $77.8M, International segment increase from $8.1M to $20.3M. Lower net loss reflects Legal settlement expenses decrease of 98% to $150K (expense).

Latest shares articles

Cellnex stock forecast
Cellnex stock forecast: BlackRock raises stake to 6.398%
Cellnex Telecom is a European telecom-infrastructure company listed in Madrid. In September, BlackRock raised its stake to 6.398% as Cellnex continued its share-buyback programme. Explore third-party CNLX price targets Past performance is not a reliable indicator of future results.
11 hours ago
Siemens stock forecast
Siemens stock forecast: VinSpeed high-speed rail contract
Siemens is a German industrial group with businesses across automation, infrastructure and mobility. On 22 September 2026, Siemens Mobility signed a high-speed rail contract with VinSpeed. Explore third-party SIE price targets. Past performance is not a reliable indicator of future results.
12 hours ago
DeFi Technologies stock forecast
DeFi Technologies stock forecast: Valour hedge fund launch
DeFi Technologies' subsidiary Valour launched its first hedge fund on 21 September 2026, expanding the business beyond exchange-traded products. Explore third-party DEFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
Buzzi Unicem logo displayed on a smartphone with a financial market chart in the background.
Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready